The evidence for use of pneumococcal conjugate over polysaccharide in children

Raymond Borrow

doi:10.4161/hv.24688

The evidence for use of pneumococcal conjugate over polysaccharide in children

Raymond Borrow^*

^*Corresponding author for this work

Manchester Meningococcal Reference Unit General

Research output: Contribution to journal › Review article › peer-review

8 Citations (Scopus)

Abstract

Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.

Original language	English
Pages (from-to)	1385-1386
Number of pages	2
Journal	Human Vaccines and Immunotherapeutics
Volume	9
Issue number	6
DOIs	https://doi.org/10.4161/hv.24688
Publication status	Published - Jun 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Conjugate
Pneumococcal
Polysaccharide
Vaccine

Access to Document

10.4161/hv.24688

Cite this

@article{574e336f652f491eaa0a0bf67bcb7bea,

title = "The evidence for use of pneumococcal conjugate over polysaccharide in children",

abstract = "Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.",

keywords = "Conjugate, Pneumococcal, Polysaccharide, Vaccine",

author = "Raymond Borrow",

year = "2013",

month = jun,

doi = "10.4161/hv.24688",

language = "English",

volume = "9",

pages = "1385--1386",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - The evidence for use of pneumococcal conjugate over polysaccharide in children

AU - Borrow, Raymond

PY - 2013/6

Y1 - 2013/6

N2 - Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.

AB - Pneumococcal glycoconjugate vaccines are now used in infant immunization schedules, globally. Pneumococcal polysaccharide vaccines are still, however, advised from the second year of life to provide broader serotype coverage. The use of these polysaccharide vaccines has been under review, especially for children.

KW - Conjugate

KW - Pneumococcal

KW - Polysaccharide

KW - Vaccine

UR - https://www.scopus.com/pages/publications/84880686070

U2 - 10.4161/hv.24688

DO - 10.4161/hv.24688

M3 - Review article

C2 - 23732895

AN - SCOPUS:84880686070

SN - 2164-5515

VL - 9

SP - 1385

EP - 1386

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 6

ER -

The evidence for use of pneumococcal conjugate over polysaccharide in children

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this